Paying more attention to chronic kidney disease in disadvantaged populations

doi:10.3877/cma.j.issn.2095-3216.2015.02.001

Abstract

Abstract:

Chronic kidney disease (CKD) has become a global public health problem due to its high prevalence, poor prognosis, and high cost. Due to the poor economic conditions, lifestyles, living environment, medical conditions, and other aspects, disadvantaged populations have a higher incidence of kidney disease, lower application rates of renal replacement therapy, worse prognosis, and heavier economic burden. Therefore, more attention should be given to CKD in disadvantaged populations. The theme of the tenth World Kidney Day 2015 is to pay attention to the CKD in disadvantaged populations, and appeal to everyone to take good care of their kidneys. This paper focuses on the relationship between poverty and CKD, and aims to improve the prevention and treatment for CKD in disadvantaged populations.

Key words: World Kidney Day, Chronic kidney disease, Disadvantaged populations, Kidney health

Yuansheng Xie, Kai Wei, Xiangmei Chen. Paying more attention to chronic kidney disease in disadvantaged populations[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2015, 04(02): 60-63.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2015.02.001

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2015/V04/I02/60

References 40

[1]	Collins AJ, Couser WG, Dirks JH, et al. World Kidney Day: an idea whose time has come [J]. J Am Soc Nephrol, 2006，17(3): 600-601.
[2]	Levey AS, Andreoli SP, DuBose T, et al. Chronic kidney disease: common, harmful, and treatable-World Kidney Day 2007 [J]. J Am Soc Nephrol, 2007, 18(2): 374-378.
[3]	Garcia-Garcia G, Jha V. World Kidney Day 2015: CKD in disadvantaged populations [J]. Am J Kidney Dis, 2015, 65(3): 394-353.
[4]	Crews DC, Charles RF, Evans MK, et al. Poverty, race, and CKD in a racially and socioeconomically diverse urban population [J]. Am J Kidney Dis, 2010, 55(6): 992-1000.
[5]	Sachs JD. Macroeconomics and health: investing in health for economic development [J]. Rev Panam Salud Publica, 2002, 12(2): 143-144.
[6]	Kalantar-Zadeh K, Block G, Humphreys MH, et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients [J]. Kidney Int, 2003, 63(3): 793-808.
[7]	Hsu C-y, Lin F, Vittinghoff E, et al. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States [J]. J Am Soc Nephrol, 2003, 14(11): 2902-2907.
[8]	Norris K, Nissenson AR. Race, gender, and socioeconomic disparities in CKD in the United States [J]. J Am Soc Nephrol, 2008, 19(7): 1261-1270.
[9]	Bruce MA, Beech BM, Crook ED, et al. Association of socioeconomic status and CKD among African Americans: the Jackson Heart Study [J]. Am J Kidney Dis, 2010, 55(6): 1001-1008.
[10]	Volkova N, McClellan W, Klein M, et al. Neighborhood poverty and racial differences in ESRD incidence [J]. J Am Soc Nephrol, 2008, 19(2): 356-364.
[11]	Sabanayagam C, Lim SC, Wong TY, et al. Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease [J]. Nephrol Dial Transplant, 2010, 25(8): 2564-2570.
[12]	McDonald S. Incidence and treatment of ESRD among indigenous peoples of Australasia[J]. Clin Nephrol, 2010, 74(Suppl 1): S28-S31.
[13]	Collins J. Kidney disease in Maori and Pacific people in New Zealand [J]. Clin Nephrol, 2010, 74 (Suppl 1): S61-S65.
[14]	Weil EJ, Nelson RG. Kidney disease among the indigenous peoples of Oceania [J]. Ethn Dis, 2005, 16(2 Suppl 2): 24-30.
[15]	Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives [J]. Lancet, 2013, 382(9888): 260-272.
[16]	Almaguer M, Herrera R, Orantes CM. Chronic kidney disease of unknown etiology in agricultural communities [J]. MEDICC Rev, 2014, 16(2): 9-15.
[17]	Obrador GT, García-García G, Villa AR, et al. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) Mexico and comparison with KEEP US [J]. Kidney Int Suppl, 2010, 77(116): S2-S8.
[18]	Gutierrez-Padilla JA, Mendoza-Garcia M, Plascencia-Perez S, et al. Screening for CKD and cardiovascular disease risk factors using mobile clinics in Jalisco, Mexico [J]. Am J Kidney Dis, 2010, 55(3): 474-484.
[19]	García-García G, Gutiérrez-Padilla AJ, Chávez-Iñiguez J, et al. Identifying undetected cases of chronic kidney disease in Mexico. Targeting high-risk populations [J]. Arch Med Res, 2013, 44(8): 623-627.
[20]	Amato D, Alvarez-Aguilar C, Castañeda-Limones R, et al. Prevalence of chronic kidney disease in an urban Mexican population [J]. Kidney Int, 2005, 68(97): S11-S17.
[21]	Ulasi II, Ijoma CK, Onodugo OD, et al. Towards prevention of chronic kidney disease in Nigeria: a community-based study in Southeast Nigeria [J]. Kidney Int Suppl, 2013, 3(2): 195-201.
[22]	Otieno LS, McLigeyo SO, Luta M. Acute renal failure following the use of herbal remedies [J]. East Afr Med J, 1991, 68(12): 993-998.
[23]	Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey [J]. Lancet, 2012, 379(9818): 815-822.
[24]	Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310(9): 948-959.
[25]	谢院生. 药物所致急性肾衰的防治经验[J]. 中国综合临床，1990, 6(2): 91-93.
[26]	Hoy W, McDonald SP. Albuminuria: marker or target in indigenous populations [J]. Kidney Int Suppl, 2004, 66(92): S25-S31.
[27]	McDonald SP, Maguire GP, Hoy WE. Renal function and cardiovascular risk markers in a remote Australian aboriginal community [J]. Nephrol Dial Transplant, 2003, 18(8): 1555-1561.
[28]	Lackland DT, Bendall HE, Osmond C, et al. Low birth weights contribute to the high rates of early-onset chronic renal failure in the southeastern United States [J]. Arch Int Med, 2000, 160(10): 1472-1476.
[29]	Bhargava SK, Sachdev HS, Fall CH, et al. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood [J]. N Engl J Med, 2004, 350(9): 865-875.
[30]	Hoy WE, Samuel T, Mott SA, et al. Renal biopsy findings among Indigenous Australians: a nationwide review [J]. Kidney Int, 2012, 82(12): 1321-1331.
[31]	Hoy W, Hughson M, Zimanyi M, et al. Distribution of volumes of individual glomeruli in kidneys at autopsy: association with age, nephron number, birth weight and body mass index [J]. Clin Nephrol, 2010, 74(Suppl 1): S105-S112.
[32]	Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end stage kidney disease: a systematic review [J]. Lancet, 2015, Epub ahead of print.
[33]	Barsoum RS. Chronic kidney disease in the developing world [J]. N Engl J Med, 2006, 354(10): 997-999.
[34]	Jha V. Current status of end-stage renal disease care in India and Pakistan [J]. Kidney Int Suppl, 2013, 3(2): 157-160.
[35]	Garcia-Garcia G, Monteon-Ramos JF, Garcia-Bejarano H, et al. Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (REDTJAL) [J]. Kidney Int Suppl, 2005, 68(97): S58-S61.
[36]	Caskey FJ. Renal replacement therapy: can we separate the effects of social deprivation and ethnicity [J]? Kidney Int Suppl, 2013, 3(2): 246-249.
[37]	Yeates KE, Cass A, Sequist TD, et al. Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation [J]. Kidney Int, 2009, 76(6): 659-664.
[38]	Garcia GG, Harden P, Chapman J, et al. The global role of kidney transplantation [J]. Lancet, 2012, 379(9820): e36-e38.
[39]	Nakai S, Iseki K, Itami N, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2010) [J]. Ther Apher Dial, 2012, 16(6): 483-521.
[40]	Jha V. Current status of chronic kidney disease care in southeast Asia [J]. Semin Nephrol, 2009, 29(5): 487-496.

Please choose a citation manager

Content to export